FDA Issues Three Draft Guidance Documents on Biosimilar Product Development; Announces May 11 Public Hearing

Published date14 March 2012
AuthorDebra A. McCurdy
Subject MatterHealth Care
Law FirmHealth Industry Washington Watch

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT